Profile
Gregory Jones has worked as a Tax Director at Aerie Pharmaceuticals, Inc. since 2020.
Gregory Jones active positions
| Companies | Position | Start |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 18/02/2020 |
Experiences
Positions held
Connections
52
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Gregory Jones
